Anti-liver FABP antibody - N-terminal
4
(1 Review)
|
(3 Publications)
Rabbit Polyclonal liver FABP antibody. N-terminal. Suitable for IHC-P, WB and reacts with Rat, Human, Mouse samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human FABP1 aa 1-50.
View Alternative Names
FABPL, FABP1, Fatty acid-binding protein 1, Liver-type fatty acid-binding protein, L-FABP
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-liver FABP antibody - N-terminal (AB190958)
Immunohistochemical analysis of formalin-fixed, paraffin-embedded human liver cancer tissue tissue labeling liver FABP with ab190958 at 1 μg/ml.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-liver FABP antibody - N-terminal (AB190958)
Immunohistochemical analysis of formalin-fixed, paraffin-embedded rat liver tissue tissue labeling liver FABP with ab190958 at 1 μg/ml.
- WB
Supplier Data
Western blot - Anti-liver FABP antibody - N-terminal (AB190958)
All lanes:
Western blot - Anti-liver FABP antibody - N-terminal (ab190958) at 0.5 µg/mL
Lane 1:
Rat liver lysate
Lane 2:
Rat kidney lysate
Lane 3:
HeLa lysate
Lane 4:
NEURO lysate
Lane 5:
SMMC lysate
Predicted band size: 14 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Liver FABP is essential for maintaining lipid homeostasis within cells. It is not part of a larger complex but acts by itself to regulate the intracellular concentration of lipids and protect cells from lipotoxicity. By sequestering fatty acids it prevents these molecules from disrupting cellular membranes or signaling pathways. Liver FABP also participates in the uptake transport and metabolic conversion of fatty acids and their metabolites influencing energy homeostasis and other vital processes.
Pathways
Liver FABP plays a significant role in the fatty acid metabolism and peroxisome proliferator-activated receptor (PPAR) signaling pathways. It acts by modulating the availability of lipid ligands necessary for PPAR activation linking it functionally to these nuclear receptors that control gene expression involved in lipid and glucose metabolism. Liver FABP's association with proteins like FABP2 and FABP4 within these pathways provides insight into its broader metabolic network highlighting its interactions in fatty acid transport and metabolism.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
PPAR research 2021:5558731 PubMed34306045
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 13: PubMed34202306
2021
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 12:e0184127 PubMed28886065
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com